Latest Breaking News On - Spinal disorders - Page 2 : comparemela.com

Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MD

Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MD
orthospinenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from orthospinenews.com Daily Mail and Mail on Sunday newspapers.

United statesVolker kh sonntagJuan uribeAclarion nociscanJodi lambertiDivision of spinal disordersCompany nasdaqCompany prospectusExchange commission onSecurities exchangeNeurosurgery at barrow neurological instituteAdvisory incAclarion incBarrow neurological instituteExchange commissionCenter authorized to perform nociscans

Karolinska Development s portfolio company OssDsign reports exceptional clinical data for its nanosynthetic bone graft product

Karolinska Development s portfolio company OssDsign reports exceptional clinical data for its nanosynthetic bone graft product
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Viktor drvotaJohan dighedKarolinska institutetKarolinska development ab nasdaq stockholmKarolinska developmentBuda health clinicNational centerInvestment fundDrug administrationNasdaq stockholmOssdsign catalystSpinal disordersDsign catalystNasdaq first north growth marketGeneral counsel

OssDsign reports exceptional data from the clinical study TOP FUSION

OssDsign reports exceptional data from the clinical study TOP FUSION
realtid.se - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from realtid.se Daily Mail and Mail on Sunday newspapers.

Morten henneveldBuda health clinicNational centerOssdsign catalystSpinal disordersDsign catalyst

OssDsign reports exceptional data from the clinical study TOP FUSION

Uppsala, January 9, 2024. OssDsign AB today announces that positive data from the clinical study TOP FUSION has been submitted to a peer-reviewed scientific journal. Top-line results show a 93 %.

Morten henneveldNational centerMetrics incBuda health clinicOssdsign catalystSpinal disordersHealth clinicDsign catalystAbuse regulation

Karolinska Development s portfolio company OssDsign reports exceptional clinical data for its nanosynthetic bone graft product

STOCKHOLM, SWEDEN, January 9, 2024. Karolinska Development AB announces that the portfolio company OssDsign reports positive data from the clinical study TOP FUSION. Top-line results show a 93%.

Viktor drvotaJohan dighedKarolinska institutetInvestment fundBuda health clinicDrug administrationNational centerKarolinska developmentKarolinska development ab nasdaq stockholmNasdaq stockholmOssdsign catalystSpinal disordersDsign catalystNasdaq first north growth marketGeneral counsel